Supply Chain Archives
06/13/2025
Expanding Clinical Trials Internationally in the ATMP Space
Expanding an advanced therapy clinical trial internationally is an exciting milestone but can be daunting for researchers and biotech teams. International trials involve challenges like country-specific regulations, Qualified Person (QP) release, and complex logistics. Early planning for these issues can help avoid delays and ensure progress.
03/24/2025
Strengthening Global ATMP Logistics: How Cryoport Systems’ Netherlands Facility Supports Temperature-Controlled Supply Chains
The success of ATMPs depends on more than just scientific breakthroughs, it requires a highly controlled, risk-mitigated supply chain that ensures product integrity from research through commercialization. With cell and gene therapies moving across multiple clinical sites, manufacturing facilities, and regulatory jurisdictions, developers need a logistics partner that can support seamless, temperature-controlled supply chain management at a global scale.
03/12/2025
The Gateway to Europe: How Cryoport Systems’ Stevenage Supply Chain Hub Supports ATMP Development
For UK-based Advanced Therapy Medicinal Product (ATMP) developers, access to European clinical trial sites and commercial markets is a critical component of a successful growth strategy. Yet, navigating regulatory barriers, customs challenges, and supply chain complexities can create unnecessary delays, increase costs, and put the integrity of sensitive biologics at risk.
03/04/2025
How Our Recent Innovative Solutions Meet Today’s Supply Chain Challenges
When advanced therapy organizations place innovation at the center of their approach to solving supply chain challenges, they prioritize the most important person involved – the waiting patient. An innovative, patient-centric approach reframes obstacles to focus on solutions that can ensure the vitality and protection of sensitive materials throughout every stage and phase of the journey to the patient’s bedside.
01/06/2025
The Future of Gene Therapy Logistics – A Pivotal Moment
Gene therapy is set to transform healthcare, but its success depends on logistics systems that can adapt and scale in line with the industry’s growth. Cryoport Systems is proud to support this exciting frontier with logistics solutions that prioritize product integrity, security, and compliance.
12/30/2024
Supporting Compliance and Reducing Risk in Gene Therapy Logistics
When it comes to high stakes logistics in the gene therapy sector, adherence to regulatory standards isn’t just a box to check—it’s essential to delivering therapies that maintain integrity from production to patient. Cryoport Systems understands the unique risks in this space and has built compliance and risk mitigation into the very design of the Cryoport Elite™ Ultra Cold shipping system.
12/23/2024
Meeting Market Needs through Collaboration and Customization
At Cryoport Systems, we understand that meaningful innovation comes not only from advanced technology but also from deeply collaborative relationships with our clients. Our collaborative approach has driven development of next-generation shipping systems and supply chain solutions, leaning on real-world insights from our clients to shape features, functionality, and future advancements.
12/16/2024
Solving Key Gene Therapy Logistics Challenges with Advanced Technology
Cryoport Systems developed the Cryoport Elite™ Ultra Cold shipping system with one mission in mind: to ensure that gene therapies reach their destination intact, uncompromised, and ready for patient treatment.
12/09/2024
